Oxford Asset Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-23,084
| Closed | -$417K | – | 2272 |
|
|
2018
Q3 | $417K | Sell |
23,084
-19,737
| -46% | -$357K | 0.01% | 1382 |
|
|
2018
Q2 | $594K | Sell |
42,821
-121,145
| -74% | -$1.68M | 0.01% | 1272 |
|
|
2018
Q1 | $1.49M | Buy |
163,966
+74,199
| +83% | +$674K | 0.03% | 733 |
|
|
2017
Q4 | $395K | Buy |
+89,767
| New | +$395K | 0.01% | 1257 |
|
|
2017
Q3 | – | Sell |
-29,927
| Closed | -$45K | – | 1815 |
|
|
2017
Q2 | $45K | Sell |
29,927
-90,632
| -75% | -$136K | ﹤0.01% | 1431 |
|
|
2017
Q1 | $310K | Sell |
120,559
-88,701
| -42% | -$228K | 0.01% | 1186 |
|
|
2016
Q4 | $534K | Buy |
209,260
+55,175
| +36% | +$141K | 0.02% | 576 |
|
|
2016
Q3 | $476K | Sell |
154,085
-44,928
| -23% | -$139K | 0.01% | 623 |
|
|
2016
Q2 | $639K | Sell |
199,013
-45,179
| -19% | -$145K | 0.02% | 559 |
|
|
2016
Q1 | $757K | Buy |
244,192
+181,620
| +290% | +$563K | 0.02% | 534 |
|
|
2015
Q4 | $253K | Sell |
62,572
-13,453
| -18% | -$54.4K | 0.01% | 771 |
|
|
2015
Q3 | $348K | Sell |
76,025
-170,386
| -69% | -$780K | 0.01% | 537 |
|
|
2015
Q2 | $1.28M | Buy |
246,411
+18,036
| +8% | +$93.6K | 0.03% | 416 |
|
|
2015
Q1 | $1.43M | Buy |
+228,375
| New | +$1.43M | 0.04% | 407 |
|
|
2014
Q2 | – | Sell |
-239,007
| Closed | -$5.69M | – | 831 |
|
|
2014
Q1 | $5.69M | Buy |
+239,007
| New | +$5.69M | 0.17% | 197 |
|
|
2013
Q4 | – | Sell |
-50,108
| Closed | -$668K | – | 849 |
|
|
2013
Q3 | $668K | Sell |
50,108
-7,986
| -14% | -$106K | 0.01% | 624 |
|
|
2013
Q2 | $763K | Buy |
+58,094
| New | +$763K | 0.02% | 629 |
|